Chelsi J Flanagan
Overview
Explore the profile of Chelsi J Flanagan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
14
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anwar A, Lu L, Plaisance C, Daniel C, Flanagan C, Wenger D, et al.
Cureus
. 2024 Mar;
16(2):e54565.
PMID: 38516474
Fluoroquinolones, a popular antibiotic class that inhibits nucleic acid synthesis of bacteria by disrupting the activity of the enzyme's topoisomerase IV and DNA gyrase, are used to treat bacterial infections....
2.
Sinnathamby E, Mason J, Flanagan C, Pearl N, Burroughs C, De Witt A, et al.
Cureus
. 2024 Jan;
15(12):e51167.
PMID: 38283489
Background: infection (CDI) is a common nosocomial infection. Risk factors for developing CDI include prior hospitalization, being older than 65 years old, antibiotic use, and chronic disease. It is linked...
3.
Dies R, Jackson C, Flanagan C, Sinnathamby E, Spillers N, Potharaju P, et al.
Cureus
. 2024 Jan;
15(12):e49782.
PMID: 38161537
Heart failure (HF) is a chronic and progressive clinical disorder characterized by an inability to pump sufficient blood to meet metabolic demands. It poses a substantial global healthcare burden, leading...
4.
Fabian I, Sinnathamby E, Flanagan C, Lindberg A, Tynes B, Kelkar R, et al.
Cureus
. 2023 Dec;
15(11):e48840.
PMID: 38106810
Topical hydroquinone (HQ) has been used for decades to treat disorders of hyperpigmentation such as melasma, post-inflammatory hyperpigmentation, and solar lentigines. Additionally, it has been used as a skin-lightening agent...
5.
Edinoff A, Flanagan C, Roberts L, Dies R, Kataria S, Jackson E, et al.
Curr Pain Headache Rep
. 2023 Aug;
27(10):615-622.
PMID: 37556044
Purpose Of Review: Regardless of the etiology, if pain persists chronically, it can detrimentally impact multiple aspects of a patient's well-being. Both physical and psychological effects are significant in many...
6.
Edinoff A, Wu N, Parker K, Dudossat E, Linquest L, Flanagan C, et al.
Adv Ther
. 2023 May;
40(6):2693-2709.
PMID: 37140707
Since their approval by the Food and Drug Administration (FDA) in 1989, proton pump inhibitors (PPIs) have become one of the most highly utilized drugs in the United States, assuming...
7.
Edinoff A, Flanagan C, Sinnathamby E, Pearl N, Jackson E, Wenger D, et al.
Curr Pain Headache Rep
. 2023 Apr;
27(7):183-192.
PMID: 37115486
Purpose Of Review: The tissue damage and trauma associated with surgery almost always result in acute postoperative pain. The intensity of postoperative pain can range from mild to severe. Naltrexone...